CXCL12 and cancer: Besides FAPα, CAF-derived SDF-1, also known as CXCL12, has been shown to promote tumor growth, motility, and tumor angiogenesis in multiple cancer types, including ovarian cancer, by interacting with the CXCR4 receptors on cancer cells [78,79,80,81,82].